Computational analysis of nearly 14,000 RuBisCO plant protein sequences identified a vast reservoir of antihypertensive peptides, with three novel ACE-inhibiting peptides (TTVW, TMW, VPCL) validated in vitro.
IC50: 12.89 μM (TTVW)Most potent of three novel RuBisCO-derived antihypertensive peptides, inhibiting ACE noncompetitively
What the researchers found
Three novel RuBisCO-derived peptides showed ACE-inhibitory activity: TTVW (IC50: 12.89 μM), TMW (IC50: 23.97 μM) as noncompetitive inhibitors, and VPCL (IC50: 339.12 μM) as a competitive inhibitor.
Why it matters
Hypertension affects over a billion people globally, and many seek dietary approaches alongside medication. Identifying potent antihypertensive peptides from the world's most abundant protein opens practical pathways for functional foods and nutraceuticals that could complement blood pressure management.
The numbers in context
12,766 large subunit and 1,020 small subunit RuBisCO sequences from angiosperms analyzed.
How the study worked
Combined in silico (simulated proteolysis of 12,766 RuBisCO large subunit and 1,020 small subunit sequences) and in vitro (ACE inhibition assays with IC50 determination and molecular docking) approach.
Who was studied
Computational analysis of 13,786 angiosperm RuBisCO sequences
What this study cannot tell us
In vitro ACE inhibition does not guarantee in vivo blood pressure reduction — peptides must survive digestion, be absorbed, and reach target tissues at effective concentrations. No animal or human studies conducted. IC50 values may not translate to clinical efficacy.
How to read the evidence
Preliminary evidence from computational prediction and in vitro validation. No in vivo data. Establishes peptide candidates for further development but not clinical application.
When this study was published
Published in 2024. Part of the growing bioactive peptide research field.
The bigger picture
Bioactive peptides from food proteins are a growing area of nutraceutical research. This study uniquely maps the antihypertensive peptide potential of the planet's most abundant protein, providing a resource that food scientists and pharmaceutical researchers can use to develop new blood pressure-lowering products.
Questions still open
- Do these peptides survive gastrointestinal digestion and reach the bloodstream in active form?
- What is the blood pressure-lowering effect of RuBisCO-derived peptides in animal models or humans?
- Could RuBisCO-rich plant foods (like leafy greens) provide meaningful antihypertensive peptide intake through normal diet?
Common questions
What is RuBisCO and why is it relevant to blood pressure?
Could eating more plants lower blood pressure through these peptides?
Read the original research
Antihypertensive peptide resources map of ribulose-1,5-bisphosphate carboxylase/oxygenases (RuBisCO) in angiosperms: Revealed by an integrated in silico and in vitro approach.
Food chemistry, 433, 137332
Citation
Shu, Haoyue; Zhao, Qingcui; Huang, Yu; Shi, Qiong; Yang, Jian. (2024). Antihypertensive peptide resources map of ribulose-1,5-bisphosphate carboxylase/oxygenases (RuBisCO) in angiosperms: Revealed by an integrated in silico and in vitro approach.. Food chemistry, 433, 137332. https://doi.org/10.1016/j.foodchem.2023.137332